Atlas Trials

Hematologic and Lymphocytic Disorder

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hematologic and Lymphocytic Disorder

RecordFirmDate
Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant (NCT04572815)Fred Hutchinson Cancer Center2021-05-14
Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation (NCT04339101)City of Hope Medical Center2020-11-11
Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation (NCT04127721)M.D. Anderson Cancer Center2020-09-22
AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission (NCT04062266)M.D. Anderson Cancer Center2019-09-13
Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer Patients (NCT03895918)Roswell Park Cancer Institute2019-01-03
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation (NCT03246906)Fred Hutchinson Cancer Center2017-09-11
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia (NCT03195010)Fred Hutchinson Cancer Center2017-06-09
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers (NCT03207854)University of Southern California2017-04-12

Track Hematologic and Lymphocytic Disorder automatically

Every clearance here is in the API, with alerts when new ones post.